DHR Danaher Corp.

$DHR 🏥 Danaher Corporation's Masimo received FDA 510(k) clearance for an atrial fibrillation detection capability on its Radius VSM pulse oximetry platform, expanding the smartSET platform designed to help clinicians identify physiological changes earlier. Actionable market event

Unusual OTM call flow on $DHR - $164K+ of the 10/23 $235 call - $82K+ of the 1/15 $250 call - $157K+ of the Jan. 2028 $290 call

$DHR Danaher reports Wednesday before the open. Consensus is 1.92 dollars EPS on 6.55 billion dollars in revenue, up 8.2% YoY (Zacks). Core organic growth is expected at just 2.5%, down from 3.0% a year ago. Diagnostics is modeled up 14.9% to 2.83 billion dollars, and Danaher closed the Masimo deal in June, which landed in that segment. Most of the headline growth is acquisition math, not underlying acceleration. Shares are up 8.9% over the past month into the print.

Danaher Teams Up With NVIDIA, Aims To Bring Accelerated Computing, Physical AI Into Labs $DHR $NVDA https://stocktwits.com/news/equity/markets/danaher-teams-up-with-nvidia-aims-to-bring-accelerated-computing-physical-ai-into-labs/cZxfZLDRBps

$DHR Our framework on Danaher Corporation yields a bullish stance, with 8 of 9 matrix cells positive and an average conviction of 3.75 out of 5. As shown in the chart attached, the only neutral reading is long-term technical momentum after an extended drawdown. Across the rest of the grid, evidence is constructive: a second-quarter earnings beat paired with raised guidance anchors the near term, while abating headwinds benefit the intermediate horizon. Sentiment aligns as well, highlighted by a twenty percent decline in short interest alongside steady institutional backing, with price holding above the 200-day moving average. We would change our mind if renewed headwinds impair free cash flow or if price breaks below the 200-day average. This reflects our read as of 21 Sep 2026—a dated snapshot, not a live call. (Disclosure: we're and this is our own research.)

$DHR: sold Danaher before Oct 20, 2022? That slice gets $0 in Hawkins. Recognized Loss only counts shares held through a corrective disclosure, and short sales count as zero too. Claims closed. Open Class Actions.

$DHR: filed in the $172.5M Danaher settlement? Keep your confirmation page and claim number. No distribution under $10 will be issued, and payments wait on final approval after the Sept 3 hearing. Claims closed. Open Class Actions.

$DHR: filed in the Danaher settlement? Payouts wait on fees too. Lead counsel can ask up to a third of the $172.5M fund plus $850K expenses, and the court has not ruled on that or final approval yet. Open Class Actions.